Avita Medical | 1811094D - 当期純利益



金融部門
株価
AUD
資産
AUD 56.39M
現金と同等
AUD 10.24M
売上原価
AUD 3.3M
流動資産
AUD 35.49M
流動負債
AUD 62.68M
負債
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
従業員
AUD 87
株当たりのEPS利益
AUD -0.38
自己資本および準備金
AUD -16.65M
売上総利益
AUD 14.31M
債務の支払利息
AUD 1.25M
借入資本
AUD 42.25M
時価総額
AUD 150.11M
当期純利益
AUD -11.62M
営業経費
AUD 28.02M
営業利益
AUD -10.41M
税引前利益
AUD -11.64M
販売収入
AUD 17.62M
販売および管理費
AUD 19.03M
株式
AUD 6.93M
貿易債権者
AUD 8.96M
貿易債務者
AUD 9.11M


当期純利益 変化する 日付
Accuray USD 2.54M 6.49M 2024-12
Celltrion KRW 8.82B 64.74M 2026-03
Clinuvel Pharmaceuticals AUD 10.44M 11.65M 2025-12
Cochlear AUD 161.5M 69.6M 2025-12
CSL USD 401M 96.5M 2025-12
Cspc Pharmaceutical CNY 370.72M 592.81M 2025-12
Deva Holding AS TRY 583.98M 319.1M 2023-09
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 7.51B 1.68B 2026-03
Kangmei Pharma CNY -16.56M 12.74M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Malin Corporation EUR -1.1M 2.2M 2023-12
Mayne Pharma AUD -103.68M 68.4M 2024-06
Medical Developments International AUD -226K 121K 2025-12
Nanosonics AUD 9.64M 4.18M 2025-12
Neuren Pharmaceuticals AUD 15.4M 7.88M 2025-12
Organigram Holdings CAD -921K 20.89M 2026-03
Ovoca Bio EUR -765K 4.89M 2025-06
Pacific Edge NZD -16.66M 2.45M 2026-06
Paradigm Biopharmaceuticals AUD -23.24M 16.82M 2025-12
Pharma Mar EUR 1.53M 58.13M 2026-03
Polynovo AUD 3K 9.87M 2025-12
PYC Therapeutics AUD -22.83M 10.46M 2025-12
Qiagen NV USD 107.83M 22.21M 2025-12
Ramsay Health Care AUD 152.7M 32.4M 2025-12
ResMed USD 398.73M 6.14M 2026-03
Sartorius EUR 56.2M 37M 2026-03
Sino Biopharmaceutical CNY 3.39B 2.91B 2025-06
Telix Pharmaceuticals AUD -4.83M 2.54M 2025-12
Tilray USD -44.93M 44.61M 2025-09
Zealand Pharma A/S -379.12M 25.12M 2025-12
Zz Pientze Pharmaceu CNY 743.48M 56.45M 2026-03